Page last updated: 2024-08-23

selegiline and Psychotic Disorders

selegiline has been researched along with Psychotic Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashi, R; Kohsaka, M; Oeda, T; Sawada, H; Sudoh, S; Sugiyama, H; Tomita, S; Umemura, A; Yamamoto, K1
Bodkin, JA; Cannon, SE; Cohen, BM; Cole, JO; Salomon, MS; Zornberg, GL1

Trials

1 trial(s) available for selegiline and Psychotic Disorders

ArticleYear
Treatment of negative symptoms in schizophrenia and schizoaffective disorder by selegiline augmentation of antipsychotic medication. A pilot study examining the role of dopamine.
    The Journal of nervous and mental disease, 1996, Volume: 184, Issue:5

    Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Depressive Disorder; Dopamine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Selegiline; Severity of Illness Index

1996

Other Studies

1 other study(ies) available for selegiline and Psychotic Disorders

ArticleYear
Subclinical elevation of plasma C-reactive protein and illusions/hallucinations in subjects with Parkinson's disease: case-control study.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Amantadine; C-Reactive Protein; Case-Control Studies; Cross-Sectional Studies; Delusions; Dopamine Agents; Hallucinations; Humans; Illusions; Levodopa; Logistic Models; Multivariate Analysis; Parkinson Disease; Psychotic Disorders; Risk Factors; Selegiline; Surveys and Questionnaires

2014